Bioequivalence of two tablet formulations of nadolol using single and multiple dose data: assessment using stereospecific and nonstereospecific assays.

Srinivas, N R; Barr, W H; Shyu, W C; Mohandoss, E; Chow, S; Staggers, J; Balan, G; Belas, F J; Blair, I A; Barbhaiya, R H

Srinivas, N R; Barr, W H; Shyu, W C; Mohandoss, E; Chow, S; Staggers, J; Balan, G; Belas, F J; Blair, I A; Barbhaiya, R H.

Affiliation

Srinivas NR; Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA.

J Pharm Sci ; 85(3): 299-303, 1996 Mar.

Article in En | MEDLINE | ID: mdl-8699333

Subject(s)

Nadolol/pharmacokinetics; Adult; Dose-Response Relationship, Drug; Humans; Male; Stereoisomerism; Therapeutic Equivalency

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Nadolol Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: J Pharm Sci Year: 1996 Document type: Article

Search on Google

XML

PubMed Links